$6.48 Million is the total value of DOMINI IMPACT INVESTMENTS LLC's 17 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 43.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | Gilead Sciences Inc. | $904,000 | +31.4% | 7,717 | +10.0% | 13.95% | +16.1% |
| STKL | Buy | Sunopta Inc. | $768,000 | +11.1% | 71,572 | +10.1% | 11.85% | -1.8% |
| OSUR | Buy | Orasure Technologies Inc. | $507,000 | -9.3% | 94,087 | +10.1% | 7.82% | -19.8% |
| OLED | Buy | Universal Display Corp. | $503,000 | +21.8% | 9,728 | +10.1% | 7.76% | +7.6% |
| AYI | Buy | Acuity Brands Inc. | $401,000 | +17.6% | 2,229 | +10.0% | 6.19% | +3.9% |
| FSLR | Buy | First Solar Inc. | $397,000 | -13.5% | 8,449 | +10.1% | 6.12% | -23.6% |
| ADSK | Buy | Autodesk Inc. | $336,000 | -5.9% | 6,701 | +10.1% | 5.18% | -16.8% |
| NGVC | Buy | Natural Grocers By Vitamin Cottage Inc. | $331,000 | -1.8% | 13,426 | +10.1% | 5.11% | -13.2% |
| CGIX | Buy | Cancer Genetics Inc. | $310,000 | +65.8% | 26,351 | +10.1% | 4.78% | +46.5% |
| CLDX | Buy | Celldex Therapeutics Inc. | $308,000 | -0.6% | 12,229 | +10.1% | 4.75% | -12.2% |
| AMRC | Buy | Ameresco Inc. Class A | $300,000 | +13.6% | 39,208 | +10.1% | 4.63% | +0.4% |
| ALR | New | Alere Inc. | $278,000 | – | 5,266 | +100.0% | 4.29% | – |
| NTUS | Buy | Natus Medical Inc. | $274,000 | +18.6% | 6,428 | +10.0% | 4.23% | +4.8% |
| SGEN | New | Seattle Genetics Inc. | $249,000 | – | 5,150 | +100.0% | 3.84% | – |
| HOLX | New | Hologic Inc. | $232,000 | – | 6,105 | +100.0% | 3.58% | – |
| SRPT | New | Sarepta Therapeutics Inc. | $231,000 | – | 7,596 | +100.0% | 3.56% | – |
| VSTM | Buy | Verastem Inc. | $153,000 | -18.6% | 20,374 | +10.1% | 2.36% | -28.1% |
| Exit | Alere Inc. | $0 | – | -4,785 | -100.0% | -4.08% | – | |
| TSLA | Exit | Tesla Motors Inc. | $0 | – | -1,237 | -100.0% | -4.08% | – |
| CREE | Exit | Cree Inc. | $0 | – | -6,650 | -100.0% | -4.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OraSure Technologies, Inc. | 25 | Q4 2019 | 16.5% |
| First Solar, Inc. | 23 | Q4 2019 | 13.3% |
| SunOpta Inc. | 22 | Q1 2019 | 17.2% |
| Ameresco Inc. Class A | 22 | Q4 2019 | 6.8% |
| Universal Display Corporation | 18 | Q4 2019 | 13.7% |
| Autodesk, Inc. | 18 | Q4 2019 | 9.5% |
| SunPower Corp. | 16 | Q4 2019 | 9.4% |
| GileadSciences, Inc. | 15 | Q4 2017 | 18.0% |
| Acuity Brands, Inc. | 15 | Q4 2019 | 12.2% |
| Hologic Inc. | 14 | Q2 2019 | 8.6% |
View DOMINI IMPACT INVESTMENTS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-05-02 |
| PX14A6G | 2024-05-02 |
| 13F-NT | 2024-02-05 |
| 13F-NT | 2023-11-08 |
| 13F-NT | 2023-08-10 |
| 13F-NT | 2023-05-05 |
| PX14A6G | 2023-05-04 |
| 13F-NT | 2023-02-13 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-08 |
View DOMINI IMPACT INVESTMENTS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.